By Priscila Mayumi Kashiwabara
29 de May de 2020
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last by Priscila Mayumi Kashiwabara
29 de May de 2025
Kasznar Leonardos was ranked on IAM Patent 1000
We are proud to announce that we have been ranked in the IAM Patent 1000 2025, a specialized ranking in the field … Kasznar Leonardos was ranked on IAM Patent 1000
15 de April de 2025
Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required
10 de April de 2025
Life Sciences Brazil Global Guide 2025 | Chambers & Partners
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2025 Global Practice Guide! Our partners Priscila Kashiwabara … Life Sciences Brazil Global Guide 2025 | Chambers & Partners